The REDUCE-AMI trial: an important step in cardiovascular drug de-prescription

Eur Heart J Acute Cardiovasc Care. 2024 May 7;13(4):370-372. doi: 10.1093/ehjacc/zuae049.

Authors

Sean van Diepen¹, Sigrun Halvorsen², Venu Menon³

Affiliations

¹ Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, Alberta, Canada.
² Department of Cardiology, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway.
³ Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.

PMID: 38608152
DOI: 10.1093/ehjacc/zuae049

No abstract available

Publication types

Editorial

MeSH terms

Cardiovascular Agents / therapeutic use
Drug Prescriptions / statistics & numerical data
Humans
Myocardial Infarction* / prevention & control
Randomized Controlled Trials as Topic

Substances

Cardiovascular Agents